Cargando…

Neural Stem Cell Transplantation for Neurodegenerative Diseases

Neurodegenerative diseases are disabling and fatal neurological disorders that currently lack effective treatment. Neural stem cell (NSC) transplantation has been studied as a potential therapeutic approach and appears to exert a beneficial effect against neurodegeneration via different mechanisms,...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Gioia, Roberta, Biella, Fabio, Citterio, Gaia, Rizzo, Federica, Abati, Elena, Nizzardo, Monica, Bresolin, Nereo, Comi, Giacomo Pietro, Corti, Stefania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247151/ https://www.ncbi.nlm.nih.gov/pubmed/32354178 http://dx.doi.org/10.3390/ijms21093103

Ejemplares similares

Animal Models of CMT2A: State-of-art and Therapeutic Implications
por: De Gioia, Roberta, et al.
Publicado: (2020)

Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic
por: Costamagna, Gianluca, et al.
Publicado: (2020)

Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model
por: Nizzardo, Monica, et al.
Publicado: (2014)

iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1
por: Simone, Chiara, et al.
Publicado: (2014)

Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights
por: Saladini, Matteo, et al.
Publicado: (2019)

Direct reprogramming of human astrocytes into neural stem cells and neurons
por: Corti, Stefania, et al.
Publicado: (2012)

Investigation of New Morpholino Oligomers to Increase Survival Motor Neuron Protein Levels in Spinal Muscular Atrophy
por: Ramirez, Agnese, et al.
Publicado: (2018)

Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)
por: Zanetta, Chiara, et al.
Publicado: (2014)

Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches
por: Nizzardo, Monica, et al.
Publicado: (2015)

Impact of COVID‐19 on the quality of life of patients with neuromuscular disorders in the Lombardy area, Italy
por: Gagliardi, Delia, et al.
Publicado: (2021)

Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers
por: Gagliardi, Delia, et al.
Publicado: (2020)

Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies
por: Salani, Sabrina, et al.
Publicado: (2012)

Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot–Marie–Tooth type 2A
por: Rizzo, Federica, et al.
Publicado: (2023)

Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
por: Nizzardo, Monica, et al.
Publicado: (2015)

Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown–Vialetto disease that is partially rescued by riboflavin
por: Rizzo, Federica, et al.
Publicado: (2017)

MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors
por: Rizzuti, Mafalda, et al.
Publicado: (2018)

Central Nervous System Involvement in Common Variable Immunodeficiency: A Case of Acute Unilateral Optic Neuritis in a 26-Year-Old Italian Patient
por: Abati, Elena, et al.
Publicado: (2018)

Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases
por: Contardo, Matilde, et al.
Publicado: (2022)

Ophthalmoplegia Due to Miller Fisher Syndrome in a Patient With Myasthenia Gravis
por: Brusa, Roberta, et al.
Publicado: (2019)

MicroRNAs as regulators of cell death mechanisms in amyotrophic lateral sclerosis
por: Gagliardi, Delia, et al.
Publicado: (2019)

Clinical and genetic features of a cohort of patients with MFN2-related neuropathy
por: Abati, Elena, et al.
Publicado: (2022)

Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
por: Bersani, Margherita, et al.
Publicado: (2022)

Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature
por: Costamagna, Gianluca, et al.
Publicado: (2020)

Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons
por: Rizzo, Federica, et al.
Publicado: (2019)

Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes
por: Rizzuti, Mafalda, et al.
Publicado: (2022)

Mitochondrial Fusion Proteins and Human Diseases
por: Ranieri, Michela, et al.
Publicado: (2013)

Growing Evidence about the Relationship between Vessel Dissection and Scuba Diving
por: Brajkovic, Simona, et al.
Publicado: (2013)

Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature
por: Gagliardi, Delia, et al.
Publicado: (2019)

Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases
por: Abati, Elena, et al.
Publicado: (2022)

Can Intestinal Pseudo-Obstruction Drive Recurrent Stroke-Like Episodes in Late-Onset MELAS Syndrome? A Case Report and Review of the Literature
por: Gagliardi, Delia, et al.
Publicado: (2019)

Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets
por: Gagliardi, Delia, et al.
Publicado: (2022)

Charcot–Marie–Tooth disease type 2F associated with biallelic HSPB1 mutations
por: Abati, Elena, et al.
Publicado: (2021)

Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies
por: Abati, Elena, et al.
Publicado: (2021)

Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence
por: Manini, Arianna, et al.
Publicado: (2022)

A novel CCM1 mutation associated with multiple cerebral and vertebral cavernous malformations
por: Lanfranconi, Silvia, et al.
Publicado: (2014)

Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies
por: Piga, Daniela, et al.
Publicado: (2019)

Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy
por: Monzio Compagnoni, Giacomo, et al.
Publicado: (2018)

Tyr78Phe Transthyretin Mutation with Predominant Motor Neuropathy as the Initial Presentation
por: Riboldi, Giulietta, et al.
Publicado: (2011)

A Novel Homozygous VPS11 Variant May Cause Generalized Dystonia
por: Monfrini, Edoardo, et al.
Publicado: (2021)

Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids
por: Costamagna, Gianluca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mqu9tplk3q23lc1ku0nbt1d8q3